<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39347437</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 Nonpharmaceutical Interventions on <i>Bordetella pertussis</i>, Human Respiratory Syncytial Virus, Influenza Virus, and Seasonal Coronavirus Antibody Levels: A Systematic Review.</ArticleTitle><Pagination><StartPage>ofae518</StartPage><MedlinePgn>ofae518</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofae518</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofae518</ELocationID><Abstract><AbstractText>During the COVID-19 pandemic, nonpharmaceutical interventions (NPIs) were introduced to reduce the spread of SARS-CoV-2. This also resulted in a reduction of notifications of other acute respiratory infections and an altered seasonality when NPIs were lifted. Without circulation of pathogens, waning of antibodies is expected, which is a first indicator of decreased immunity. Here, by performing a systematic literature review, we investigated whether reduced antibody levels due to waning immunity contributed to the altered seasonality after NPIs were lifted. Thirteen articles met the inclusion criteria and reported antibody levels or seroprevalence of human respiratory syncytial virus, seasonal human coronavirus, <i>Bordetella pertussis</i>, and influenza virus. We show that the COVID-19 pandemic most likely led to waning of pathogen-specific antibodies, with the strongest evidence for human respiratory syncytial virus and seasonal human coronavirus and with a larger decrease in children vs adults. Waning antibodies might have resulted in out-of-season activity for these pathogens.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gaasbeek</LastName><ForeName>Channah M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0009-0004-8809-2241</Identifier><AffiliationInfo><Affiliation>Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, RIVM, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visser</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, RIVM, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>Rory D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koopmans</LastName><ForeName>Marion</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5204-2312</Identifier><AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Binnendijk</LastName><ForeName>Rob</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, RIVM, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>den Hartog</LastName><ForeName>Gerco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, RIVM, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">antibody waning</Keyword><Keyword MajorTopicYN="N">respiratory pathogens</Keyword><Keyword MajorTopicYN="N">seasonality of infection</Keyword><Keyword MajorTopicYN="N">seroprevalence</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. All authors: No reported conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>10</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39347437</ArticleId><ArticleId IdType="pmc">PMC11430909</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofae518</ArticleId><ArticleId IdType="pii">ofae518</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Safiri  S, Mahmoodpoor  A, Kolahi  AA, et al.  Global burden of lower respiratory infections during the last three decades. Front Public Health  2022; 10:1028525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9869262</ArticleId><ArticleId IdType="pubmed">36699876</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Commission . Commission implementing decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Official Journal of the European Union 2018. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945&amp;from=EN#page=22. Accessed on 20 October 2023.</Citation></Reference><Reference><Citation>Moriyama  M, Hugentobler  WJ, Iwasaki  A. Seasonality of respiratory viral infections. Annu Rev Virol  2020; 7:83–101.</Citation><ArticleIdList><ArticleId IdType="pubmed">32196426</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu  WK, Liu  Q, Chen  DH, et al.  Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study. PLoS One  2014; 9:e96674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010508</ArticleId><ArticleId IdType="pubmed">24797911</ArticleId></ArticleIdList></Reference><Reference><Citation>Obasi  CN, Barrett  B, Brown  R, et al.  Detection of viral and bacterial pathogens in acute respiratory infections. J Infect  2014; 68:125–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3947238</ArticleId><ArticleId IdType="pubmed">24211414</ArticleId></ArticleIdList></Reference><Reference><Citation>Esneau  C, Duff  AC, Bartlett  NW. Understanding rhinovirus circulation and impact on illness. Viruses  2022; 14:141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778310</ArticleId><ArticleId IdType="pubmed">35062345</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves  HE, Piché-Renaud  PP, Peci  A, et al.  The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: a population-based study. Lancet Reg Health Am  2021; 1:100015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285668</ArticleId><ArticleId IdType="pubmed">34386788</ArticleId></ArticleIdList></Reference><Reference><Citation>van Summeren  J, Meijer  A, Aspelund  G, et al.  Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?  Euro Surveill  2021; 26:2100639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299745</ArticleId><ArticleId IdType="pubmed">34296672</ArticleId></ArticleIdList></Reference><Reference><Citation>Klous  G, McDonald  S, de Boer  P, van Hoek  A, Franz  E, van Rooijen  M.  Staat van Infectieziekten in Nederland, 2021. Bilthoven, the Netherlands: Rijksinstituut voor Volksgezondheid en Milieu, 2022.</Citation></Reference><Reference><Citation>Falkenstein-Hagander  K, Appelqvist  E, Cavefors  AF, et al.  Waning infant pertussis during COVID-19 pandemic. Arch Dis Child  2022; 107:e19.</Citation><ArticleIdList><ArticleId IdType="pubmed">34857511</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessier  E, Campbell  H, Ribeiro  S, et al.  Impact of the COVID-19 pandemic on Bordetella pertussis infections in England. BMC Public Health  2022; 22:405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882439</ArticleId><ArticleId IdType="pubmed">35220973</ArticleId></ArticleIdList></Reference><Reference><Citation>Matczak  S, Levy  C, Fortas  C, et al.  Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020. Euro Surveill  2022; 27:2100933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9229195</ArticleId><ArticleId IdType="pubmed">35748301</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh  K, Jung  J, Hong  J, et al.  Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: a nationwide surveillance study. Clin Infect Dis  2021; 72:e184–91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665442</ArticleId><ArticleId IdType="pubmed">33150393</ArticleId></ArticleIdList></Reference><Reference><Citation>Edridge  AWD, Kaczorowska  J, Hoste  ACR, et al.  Seasonal coronavirus protective immunity is short-lasting. Nat Med  2020; 26:1691–3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929268</ArticleId></ArticleIdList></Reference><Reference><Citation>den Hartog  G, van Kasteren  PB, Schepp  RM, Teirlinck  AC, van der Klis  FRM, van Binnendijk  RS. Decline of RSV-specific antibodies during the COVID-19 pandemic. Lancet Infect Dis  2023; 23:23–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714975</ArticleId><ArticleId IdType="pubmed">36463892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogilvie  MM, Vathenen  AS, Radford  M, Codd  J, Key  S. Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol  1981; 7:263–71.</Citation><ArticleIdList><ArticleId IdType="pubmed">7038043</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbers  G, Mollema  L, van der Klis  F, den Hartog  G, Schepp  R. Antibody responses to respiratory syncytial virus: a cross-sectional serosurveillance study in the Dutch population focusing on infants younger than 2 years. J Infect Dis  2021; 224:269–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280491</ArticleId><ArticleId IdType="pubmed">32964923</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher  D, Shamseer  L, Clarke  M, et al.  Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) 2015 statement. Syst Rev  2015; 4:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawfik  GM, Dila  KAS, Mohamed  MYF, et al.  A step by step guide for conducting a systematic review and meta-analysis with simulation data. Trop Med Health  2019; 47:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6670166</ArticleId><ArticleId IdType="pubmed">31388330</ArticleId></ArticleIdList></Reference><Reference><Citation>Pluijmaekers  A, de Melker  H. Het Rijksvaccinatieprogramma in Nederland Surveillance en ontwikkelingen in 2021–2022. Bilthoven, the Netherlands: Rijksinstituut voor Volksgezondheid en Milieu, 2022.</Citation></Reference><Reference><Citation>

Wells  G, Shea  B, O’Connell  D, et al.   The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2011. Available at: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed on 29 December 2023.</Citation></Reference><Reference><Citation>Hale  T, Angrist  N, Goldszmidt  R, et al.  A global panel database of pandemic policies (Oxford COVID-19 government response tracker). Nat Hum Behav  2021; 5:529–38.</Citation><ArticleIdList><ArticleId IdType="pubmed">33686204</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobben  M, Van Der Straten  K, Brouwer  PJ, et al.  Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. Elife  2021; 10:e70330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610423</ArticleId><ArticleId IdType="pubmed">34812143</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong  SPJ, Felix Garza  ZC, Gibson  JC, et al. Potential impacts of prolonged absence of influenza virus circulation on subsequent epidemics. bioRxiv. Preprint posted online 16 November 2022. doi:10.1101/2022.02.05.22270494</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.05.22270494</ArticleId></ArticleIdList></Reference><Reference><Citation>Reicherz  F, Xu  RY, Abu-Raya  B, et al.  Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic. J Infect Dis  2022; 226:2064–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129162</ArticleId><ArticleId IdType="pubmed">35524952</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobben  M, Juncker  HG, van der Straten  K, et al.  Decreased passive immunity to respiratory viruses through human milk during the COVID-19 pandemic. Microbiol Spectr  2022; 10:e0040522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9431045</ArticleId><ArticleId IdType="pubmed">35762813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen  Z, Pang  J, Zhang  Y, et al.  Seroprevalence of pertussis in adults at childbearing age pre– and post–COVID-19 in Beijing, China. Vaccines (Basel)  2022; 10:872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9227865</ArticleId><ArticleId IdType="pubmed">35746480</ArticleId></ArticleIdList></Reference><Reference><Citation>Pletz  MW, Dürrwald  R, Reiche  J, Rose  N, Scherag  A, Weis  S. Impact of the COVID-19 pandemic on influenza and respiratory syncytial virus antibody titres in the community: a prospective cohort study in Neustadt, Thuringia, Germany. Eur Respir J  2022; 60:2200947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9647071</ArticleId><ArticleId IdType="pubmed">36180083</ArticleId></ArticleIdList></Reference><Reference><Citation>De Thoisy  A, Woudenberg  T, Pelleau  S, et al.  Seroepidemiology of the seasonal human coronaviruses NL63, 229E, OC43 and HKU1 in France. Open Forum Infect Dis  2023; 10:ofad340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10368309</ArticleId><ArticleId IdType="pubmed">37496603</ArticleId></ArticleIdList></Reference><Reference><Citation>Reicherz  F, Golding  L, Lavoie  PM, Abu-Raya  B. Decay of anti–Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures. Vaccine  2022; 40:3746–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9091163</ArticleId><ArticleId IdType="pubmed">35599039</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen  Q, Wang  W, Shi  X, et al.  Seroepidemiology of pertussis in the east of China: estimates of incidence of infection in adolescents and adults pre– and post–COVID-19. Front Public Health  2022; 10:1054617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9754053</ArticleId><ArticleId IdType="pubmed">36530663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkema  RS, Bruin  E, Ramakers  C, et al.  Reduced seasonal coronavirus antibody responses in children following COVID-19 mitigation measures, the Netherlands. Viruses  2023; 15:212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9862716</ArticleId><ArticleId IdType="pubmed">36680252</ArticleId></ArticleIdList></Reference><Reference><Citation>Our World in Data. Coronavirus pandemic (COVID-19). 2020. Available at: https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>
European Centre for Disease Prevention and Control . Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA. 2022. Available at: https://www.ecdc.europa.eu/en/publications-data/intensified-circulation-respiratory-syncytial-virus-rsv-and-associated-hospital. Accessed 20 October 2023.</Citation></Reference><Reference><Citation>Meslé  MMI, Sinnathamby  M, Mook  P, et al.  Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022. Influenza Other Respir Viruses  2023; 17:e13219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10661829</ArticleId><ArticleId IdType="pubmed">38025589</ArticleId></ArticleIdList></Reference><Reference><Citation>Petros  BA, Milliren  CE, Sabeti  PC, Ozonoff  A. Increased pediatric respiratory syncytial virus case counts following the emergence of SARS-CoV-2 can be attributed to changes in testing. Clin Infect Dis  2024; 78:1707–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11175668</ArticleId><ArticleId IdType="pubmed">38602423</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygaard  U, Hartling  UB, Nielsen  J, et al.  Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide cohort study. Lancet Child Adolesc Health  2023; 7:171–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9940917</ArticleId><ArticleId IdType="pubmed">36634692</ArticleId></ArticleIdList></Reference><Reference><Citation>Loconsole  D, Centrone  F, Rizzo  C, et al.  Out-of-season epidemic of respiratory syncytial virus during the COVID-19 pandemic: the high burden of child hospitalization in an academic hospital in southern Italy in 2021. Children (Basel)  2022; 9:848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9221938</ArticleId><ArticleId IdType="pubmed">35740785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdeau  M, Vadlamudi  NK, Bastien  N, et al.  Pediatric RSV-associated hospitalizations before and during the COVID-19 pandemic. JAMA Netw Open  2023; 6:e2336863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10551765</ArticleId><ArticleId IdType="pubmed">37792376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumley  SF, Richens  N, Lees  E, et al.  Changes in paediatric respiratory infections at a UK teaching hospital 2016–2021; impact of the SARS-CoV-2 pandemic. J Infect  2022; 84:40–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591975</ArticleId><ArticleId IdType="pubmed">34757137</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Centre for Disease Prevention and Control . Seasonal influenza 2022–2023. 2023. Available at: https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-annual-epidemiological-report-20222023. Accessed 18 December 2023.</Citation></Reference><Reference><Citation>Caini  S, Meijer  A, Nunes  MC, et al.  Is influenza B/Yamagata extinct and what public health implications could this have? An updated literature review and comprehensive assessment of global surveillance databases. medRxiv. Preprint posted online 25 September 2023. doi:10.1101/2023.09.25.23296068</Citation></Reference><Reference><Citation>Versteegen  P, Berbers  GAM, Smits  G, et al.  More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands. Lancet Reg Health Eur  2021; 10:100196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589709</ArticleId><ArticleId IdType="pubmed">34806066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sande  CJ, Mutunga  MN, Okiro  EA, Medley  GF, Cane  PA, Nokes  DJ. Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort. J Med Virol  2013; 85:2020–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3798117</ArticleId><ArticleId IdType="pubmed">23983183</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>